2.A myriad of electrocardiographic findings associated with digoxin use.
Andie Hartanto DJOHAN ; Ching-Hui SIA ; Devinder SINGH ; Weiqin LIN ; William Kok-Fai KONG ; Kian-Keong POH
Singapore medical journal 2020;61(1):9-14
Digoxin is a commonly prescribed drug in the management of heart failure and atrial fibrillation. Despite its widespread use, most clinicians have little experience with recognising clinical signs and symptoms that might suggest a potentially lethal drug toxicity. We herein describe two cases with specific reference to the electrocardiographic changes induced by digoxin and discuss the predisposing factors for toxicity, recognition of possible toxicity and treatment approaches.
3.Association of face mask use with self-reported cardiovascular symptoms during the COVID-19 pandemic.
Nicholas Wen SHENG CHEW ; Raymond Ching CHIEW WONG ; Andie Hartanto DJOHAN ; Jinghao Nicholas NGIAM ; Ping CHAI ; Tiong-Cheng YEO ; Huay-Cheem TAN ; Ching-Hui SIA
Singapore medical journal 2023;64(10):609-615
INTRODUCTION:
Countries are mandating the use of face masks to stem the spread of coronavirus disease 2019 (COVID-19). Face mask use has been associated with discomfort due to its effects on thermoregulation, breathing and oxygenation. We evaluated the prevalence and severity of self-reported cardiovascular symptoms before and during face mask use.
METHODS:
This was a cross-sectional study of 1,001 participants residing in Singapore, who participated in a self-administered questionnaire between 25 April 2020 and 4 May 2020. Symptom severity before and during mask use, and health-seeking behaviour information were collected. The study outcome was self-reported worsening of cardiovascular symptoms and its association with the type of mask worn, duration of mask worn per day, and intensity of physical activities during mask use.
RESULTS:
The most common symptom reported during mask use was dyspnoea. Independent predictors for self-reported cardiovascular symptoms during mask use were moderate-high physical activity during mask use (odds ratio [OR] 1.634, 95% confidence interval [CI] 1.176-2.270, P = 0.003), duration of mask use for ≥3 h (OR 1.672, 95% CI 1.189-2.352, P = 0.003) and type of mask used, after adjusting for age, sex, healthcare-based worker status and presence of comorbidities. N95 mask was associated with worse symptoms when compared to surgical mask. Participants with ≥3 worsening symptoms or worsening dyspnoea, palpitations, fatigue and dizziness were more likely to seek medical help.
CONCLUSION
Face mask use has been proven to be an effective way in curbing COVID-19 transmission. However, participants in this study had concerns regarding its use and these concerns should be urgently addressed to enable mask use policies to be enacted.
Humans
;
COVID-19/epidemiology*
;
Pandemics
;
Masks/adverse effects*
;
Self Report
;
Cross-Sectional Studies
;
Dyspnea/etiology*